(TheNewswire)
Vancouver, B C - TheNewswire - January 27, 2023 - BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN ) (CSE: BYND ) (" BYNDCannasoft " or the " Company ") is pleased to announce today that it has filed apreliminary short form base shelf prospectus (the “ Prospectus “ ).
The Prospectus was filed with the securities regulatoryauthorities in each of the Provinces and Territories of Canada. TheProspectus was filed to provide the Company with financial flexibilityand efficient access to Canadian capital markets to pursue its growthinitiatives. A copy of the Prospectus is available under theCompany’s profile on SEDAR at www.sedar.com .
Once a receipt for the final Prospectus is receivedfrom the applicable securities regulators, the final Prospectus willbe valid for a 25-month period during which time the Company will bepermitted to offer up to $30 million of common shares, preferredshares, warrants, subscription receipts, debt securities, or anycombination thereof, including in the form of units (collectively, the“ Securities “).
If any Securities are offered under the Prospectus, theterms of any such Securities and the intended use of the net proceedsresulting from such offering would be established at the time of anyoffering and would be described in a prospectus supplement filed withthe applicable Canadian securities regulatory authorities at the timeof such offering and would be made available by the Company.
This press release does not constitute an offer to sellor the solicitation of an offer to buy Securities, nor will there beany sale of the Securities in any jurisdiction in which such offer,solicitation or sale would be unlawful prior to the registration orqualification under securities laws of any such jurisdiction.
The Canadian Securities Exchange has not reviewed,approved, or disapproved the content of this news release.
About BYND Cannasoft Enterprises Inc.
BYND Cannasoft Enterprises is an Israeli-based integrated software andcannabis company. BYND Cannasoft owns and markets "BenefitCRM," a proprietary customer relationship management (CRM)software product enabling small and medium?sized businesses tooptimize their day?to?day business activities such as salesmanagement, personnel management, marketing, call center activities,and asset management. Building on our 20 years of experience in CRMsoftware, BYND Cannasoft is developing an innovative new CRM platformto serve the needs of the medical cannabis industry by making it amore organized, accessible, and price-transparent market. The CannabisCRM System will include a Job Management (BENEFIT) and a module system(CANNASOFT) for managing farms and greenhouses with varied crops. BYNDCannasoft owns the patent-pending intellectual property for the EZ-Gdevice. This therapeutic device uses proprietary software to regulatethe flow of low concentrations of CBD oil, hemp seed oil, and othernatural oils into the soft tissues of the female reproductive systemto potentially treat a wide variety of women's health issues. The EZ-Gdevice includes technological advancements as a sex toy with a morerealistic experience and the prototype utilizes sensors to determinewhat enhances the users' pleasure. The user can control the devicethrough a Bluetooth app installed on a smartphone or other portabledevice. The data will be transmitted and received from the device toand from the secure cloud using artificial intelligence (AI). The datais combined with other antonymic user preferences to improve itsoperation by increasing sexual satisfaction.
For Further Information please refer to information available on the Company’swebsite: www.cannasoft-crm.com , theCSE’s website: www.thecse.com/en/listings/life-sciences/bynd-cannasoft-enterprises-inc and on SEDAR: www.sedar.com .
Gabi Kabazo
Chief Financial Officer
Tel: (604) 833-6820
e?mail: ir@cannasoft-crm.com
Cautionary Note RegardingForward-Looking Statements
This press release includes certain statements that maybe deemed “forward-looking statements” including statementsregarding the filing of a final Prospectus. All statements in thisrelease, other than statements of historical facts, that addressfuture events or developments that the Company expects, areforward-looking statements. Although the Company believes theexpectations expressed in such forward-looking statements are based onreasonable assumptions, such statements are not guarantees of futureperformance, and actual events or developments may differ materiallyfrom those in forward-looking statements. Such forward-lookingstatements necessarily involve known and unknown risks anduncertainties, which may cause the Company’s actual performance andfinancial results in future periods to differ materially from anyprojections of future performance or results expressed or implied bysuch forward-looking statements. In particular, statements regarding our Cannabis CRM platform, and thepotential of the EZ-G device to treat a wide variety of women's health issues. Additional regulatory standards may be required, includingFDA approval or any other approval for the purpose of manufacturing,marketing, and selling the device under therapeutic indications. Thereis no certainty that the aforementioned approvals will be received.Such statements reflect the Company's current views with respect tofuture events and are subject to such risks and uncertainties. Manyfactors could cause actual results to differ materially from thestatements made, including unanticipated regulatory requests anddelays, final patents approval, and those factors discussed in filingsmade by the Company with the Canadian securities regulatoryauthorities, including (without limitation) in the company'smanagement's discussion and analysis for the nine month period endedSeptember 30, 2022 and annual information formdated October 8, 2022, which are available under the company's profileat www.sedar.com , and in filings made with the U.S. Securities and ExchangeCommission. Should one or more of these factors occur, or shouldassumptions underlying the forward-looking statements prove incorrect,actual results may vary materially from those described herein asintended, planned, anticipated, or expected. We do not intend and donot assume any obligation to update these forward?lookingstatements, except as required by law. Any such forward-lookingstatements represent management's estimates as of the date of thispress release. While we may elect to update such forward-lookingstatements at some point in the future, we disclaim any obligation todo so, even if subsequent events cause our views to change.Shareholders are cautioned not to put undue reliance on suchforward?looking statements.
This press release does not constitute an offer to sellor a solicitation of an offer to buy any of the securities in theUnited States. The securities have not been and will not be registeredunder the United States Securities Act of 1933, as amended (the“U.S. Securities Act”) or any state securities laws and may not beoffered or sold within the United States or to U.S. Persons unlessregistered under the U.S. Securities Act and applicable statesecurities laws or an exemption from such registration is available.Not for distribution to U.S. Newswire Services or for dissemination inthe United States. Any failure to comply with this restriction mayconstitute a violation of U.S. Securities laws.
Copyright (c) 2023 TheNewswire - All rights reserved.